Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pulmonary Stereotactic Radiotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT07608159
What this trial is testing

Neoadjuvant SF-SBRT Plus Toripalimab and Chemotherapy in Resectable Stage II-III NSCLC.

Who this might be right for
Non Small Cell Lung CancerStereotactic Body RadiotherapyNeoadjuvant Chemoimmunotherapy+1 more
Shanghai Pulmonary Hospital, Shanghai, China 201
Early research (Phase 1)Ended earlyNCT03307759
What this trial is testing

Sequencing of Stereotactic Ablative Body Radiotherapy in Combination With PD-1 Blockade Using Pembrolizumab in Metastatic Non-Small Cell Lung Carcinoma

Who this might be right for
Non-small Cell Lung Cancer
Peter MacCallum Cancer Centre, Australia 13
Testing effectiveness (Phase 2)Looking for participantsNCT06582940
What this trial is testing

Elimination of PTV Margins Based on MRI-guided Adaptive Stereotactic Radiotherapy for Non-small Cell Lung Cancer With Brain Metastasis

Who this might be right for
MRI-guided Adaptive RadiotherapyNon-small Cell Lung CancerBrain Metastasis
Sun Yat-sen University 168
Not applicableEnded earlyNCT03624907
What this trial is testing

Daily vs. Non-Daily SBRT for NSCLC

Who this might be right for
Non-small Cell Lung Cancer
University of Florida 20
Testing effectiveness (Phase 2)Looking for participantsNCT07132190
What this trial is testing

Stereotactic Radiation for Growing/Changing Brain Metastases With Same-Day Radiation Planning and Treatment With Margin Reduction

Who this might be right for
Brain Metastases, AdultBrain Tumor - MetastaticBrain Metastases From Non-small Cell Lung Cancer (NSCLC)+1 more
Ayal A. Aizer, MD 60
Large-scale testing (Phase 3)Looking for participantsNCT02468024
What this trial is testing

JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
University of Texas Southwestern Medical Center 272
Not applicableNot Yet RecruitingNCT07334990
What this trial is testing

Impact of a Hypnotic Recording on Artifacts in 4D CT in the Context of Stereotactic Body Radiation Therapy for Lung Cancer

Who this might be right for
Stereotactic Body Radiation TherapyLung Lesions
Centre Leon Berard 25
Testing effectiveness (Phase 2)Study completedNCT00888823
What this trial is testing

Phase I/II Study of Fractionated Stereotactic Radiotherapy for Early Stage Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
AHS Cancer Control Alberta 13
Not applicableUnknownNCT02561559
What this trial is testing

SBRT Treatment for Lung Metastasis From Soft Tissue Sarcoma

Who this might be right for
Metastasis From Malignant Tumor of Soft Tissues
Istituto Clinico Humanitas 37
Not applicableActive Not RecruitingNCT02417662
What this trial is testing

Stereotactic Ablative Radiotherapy for Oligometastatic Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
University College, London 140
Testing effectiveness (Phase 2)WithdrawnNCT00471835
What this trial is testing

Stereotactic Body Radiation Therapy in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Wake Forest University Health Sciences
Testing effectiveness (Phase 2)Active Not RecruitingNCT03667820
What this trial is testing

Study of Osimertinib and Stereotactic Ablative Radiation (SABR) in EGFR Mutant NSCLC

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
University of Texas Southwestern Medical Center 41
Not applicableLooking for participantsNCT06815289
What this trial is testing

MR-informed Stereotactic Radiotherapy for Treatment of Ultracentral Lung Tumours Utilising a Dedicated MR-simulator for Daily Adaptation Followed by CBCT-guided Treatment Delivery

Who this might be right for
Primary Lung Cancer or Secondary Lung Metastases
University of Zurich 11
Not applicableLooking for participantsNCT07824583
What this trial is testing

A Study Evaluating a New Radiation Treatment Workflow (NGDS)

Who this might be right for
Lung Cancer (Diagnosis)Liver Cancer, AdultPancreatic Cancer+2 more
Varian, a Siemens Healthineers Company 20
Testing effectiveness (Phase 2)UnknownNCT05520853
What this trial is testing

SBRT Combined With PD-1 Inhibitor and Thoracic Hyperthermia for Advanced NSCLC

Who this might be right for
Stereotactic Body Radiation Therapy; PD-1 Inhibitor; Hyperthermia; NSCLC
First People's Hospital of Hangzhou 63
Not applicableActive Not RecruitingNCT03143322
What this trial is testing

Standard Treatment +/- SBRT in Solid Tumors Patients With Between 1 and 5 Bone-only Metastases

Who this might be right for
Metastatic Breast CancerMetastatic Lung CancerMetastatic Prostate Cancer+1 more
UNICANCER 168
Testing effectiveness (Phase 2)Looking for participantsNCT04933903
What this trial is testing

BrUOG 397: NEO Rad (LOW): Neoadjuvant Low Dose Stereotactic Body Radiotherapy, Ipilimumab and Nivolumab

Who this might be right for
Non Small Cell Lung Cancer
Brown University 25
Not applicableUnknownNCT03921957
What this trial is testing

Study of the Decrease of Length of Stereotactic Body Radiation Therapy in Lung Cancer

Who this might be right for
Stage IA - IB Non Small Cell Lung Cancer
Centre Paul Strauss 38
Not applicableNot Yet RecruitingNCT05411809
What this trial is testing

The ctDNA for Evaluating Whether to Use Adjuvant Therapy After SBRT in Patients With Early Lung Cancer

Who this might be right for
Stereotactic Body Radiation Therapy
Peking University Third Hospital 180
Testing effectiveness (Phase 2)Looking for participantsNCT06877299
What this trial is testing

Low-Dose Radiation + SBRT + Tislelizumab Plus Platinum-based Chemotherapy in Stage ⅡA-ⅢB Non-small Cell Lung Cancer

Who this might be right for
Lung CancerNon-small Cell Lung Cancer
Sichuan University 30
Next Page